What is DA Davidson’s Estimate for Clorox Q2 Earnings?

The Clorox Company (NYSE:CLXFree Report) – Stock analysts at DA Davidson issued their Q2 2025 earnings estimates for shares of Clorox in a research report issued on Monday, November 4th. DA Davidson analyst L. Weiser anticipates that the company will earn $1.27 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $171.00 target price on the stock. The consensus estimate for Clorox’s current full-year earnings is $6.79 per share.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the firm earned $0.49 earnings per share. The company’s quarterly revenue was up 27.0% on a year-over-year basis.

Other research analysts have also recently issued reports about the company. Deutsche Bank Aktiengesellschaft boosted their price target on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Wells Fargo & Company reduced their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. JPMorgan Chase & Co. raised their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $151.57.

Check Out Our Latest Stock Report on CLX

Clorox Price Performance

NYSE CLX opened at $162.48 on Tuesday. The stock has a market cap of $20.11 billion, a price-to-earnings ratio of 56.61, a PEG ratio of 3.09 and a beta of 0.41. Clorox has a 12 month low of $125.46 and a 12 month high of $169.09. The company’s 50 day moving average is $161.63 and its two-hundred day moving average is $146.33. The company has a current ratio of 1.00, a quick ratio of 0.63 and a debt-to-equity ratio of 11.08.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox’s dividend payout ratio (DPR) is 170.04%.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.57% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Clorox

A number of institutional investors and hedge funds have recently bought and sold shares of CLX. Vanguard Group Inc. lifted its holdings in shares of Clorox by 0.3% in the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after purchasing an additional 48,632 shares during the last quarter. Nuance Investments LLC increased its holdings in shares of Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after acquiring an additional 960,094 shares during the period. Van ECK Associates Corp raised its position in Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after purchasing an additional 31,510 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Clorox by 14.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after purchasing an additional 120,716 shares during the period. Finally, Acadian Asset Management LLC grew its position in Clorox by 26.5% during the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after purchasing an additional 184,847 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.